Evolent Health Inc [EVH] Director makes an insider purchase of 2,735 shares worth 25518.0.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Evolent Health Inc shares valued at $25,518 were purchased by Holder Diane on Mar 06 ’25. At $9.33 per share, Holder Diane acquired 2,735 shares. The insider’s holdings grew to 70,584 shares worth approximately $0.76 million following the completion of this transaction.

Also, McCarthy Daniel Joseph purchased 11,040 shares, netting a total of over 99,470 in proceeds. Following the buying of shares at $9.01 each, the insider now holds 389,004 shares.

Before that, Jelinek Richard M had added 30,000 shares to its account. In a trade valued at $273,750, the Director bought Evolent Health Inc shares for $9.12 each. Upon closing the transaction, the insider’s holdings increased to 30,000 shares, worth approximately $0.16 million.

As published in their initiating research note from Needham on January 10, 2025, Evolent Health Inc [EVH] has been a Buy and the price target has been revised to $15. Analysts at BTIG Research resumed the stock at ‘”a Buy”‘ outlook in a report released in early December. As of November 08, 2024, Stephens has decreased its “an Overweight” rating to a “an Equal-weight” for EVH. Earlier on October 11, 2024, KeyBanc Capital Markets initiated its rating. Their recommendation was “an Overweight” for EVH stock.

Analyzing EVH Stock Performance

On last trading session,, Evolent Health Inc [NYSE: EVH] rose 0.85% to $10.71. The stock’s lowest price that day was $10.39, but it reached a high of $10.8 in the same session. During the last five days, there has been a surge of approximately 26.15%. Over the course of the year, Evolent Health Inc shares have dropped approximately -52.40%. Shares of the company reached a 52-week high of $12.98 on 01/10/25 and a 52-week low of $7.06 on 05/23/25.

Support And Resistance Levels for Evolent Health Inc (EVH)

According to the 24-hour chart, there is a support level at 10.46, which, if violated, would cause prices to drop to 10.22. In the upper region, resistance lies at 10.88. The next price resistance is at 11.06. RSI (Relative Strength Index) is 70.39 on the 14-day chart, showing overbought technical sentiment.

Is Evolent Health Inc subject to short interest?

Stocks of Evolent Health Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.7 million shares to 17.46 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 16.75 million shares. A jump of 4.03% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.97 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.97.

Which companies own the most shares of Evolent Health Inc (EVH)?

In terms of Evolent Health Inc share price expectations, FactSet research, analysts set an average price target of 17.5 in the next 12 months, up nearly 64.78% from the previous closing price of $10.62. Analysts anticipate Evolent Health Inc stock to reach 20 by 2025, with the lowest price target being 14. In spite of this, 5 analysts ranked Evolent Health Inc stock as Buy at the end of 2025. On August 09, 2024, Truist assigned a price target of “a Buy” to the stock and upgraded coverage with a $33.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.